Allarity Therapeutics, Inc.

NasdaqCM:ALLR Stok Raporu

Piyasa değeri: US$1.9m

Allarity Therapeutics Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Allarity Therapeutics's earnings are forecast to decline at 10.2% per annum while its annual revenue is expected to grow at 115.8% per year. EPS is expected to grow by 31% per annum.

Anahtar bilgiler

-10.2%

Kazanç büyüme oranı

31.0%

EPS büyüme oranı

Biotechs kazanç büyümesi27.1%
Gelir büyüme oranı115.8%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme02 May 2024

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Allarity Therapeutics GAAP EPS of -$0.72 misses by $0.46

Oct 11

Allarity Therapeutics GAAP EPS of -$0.52 misses by $0.07

Aug 23

Allarity Therapeutics appoints interim CEO, CFO

Jun 29

Kazanç ve Gelir Büyüme Tahminleri

NasdaqCM:ALLR - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/2026N/A-33N/AN/A1
12/31/2025N/A-29N/AN/A1
12/31/2024N/A-16N/AN/A1
6/30/2024N/A-13-16-16N/A
3/31/2024N/A-21-11-11N/A
12/31/2023N/A-20-13-13N/A
9/30/2023N/A-22-14-14N/A
6/30/2023N/A-23-13-13N/A
3/31/2023N/A-20-14-14N/A
12/31/2022N/A-21-17-17N/A
9/30/2022N/A-35-19-19N/A
6/30/2022N/A-29-18-18N/A
3/31/2022N/A-28-18-18N/A
12/31/2021N/A-27-15-15N/A
9/30/2021-1-12-13-13N/A
6/30/2021-1-12-11-11N/A
3/31/2021N/A-7-8-8N/A
12/31/2020N/A-7-7-7N/A
9/30/20201-16-7-7N/A
6/30/20201-17-8-8N/A
3/31/20200-20-10-10N/A
12/31/20190-20-11-11N/A
9/30/20190-11-11-10N/A
6/30/20191-8-9-9N/A
3/31/20191-4-7-6N/A
12/31/20181-2-4-4N/A
9/30/20182-1-2-2N/A
6/30/20181-1-2-2N/A
3/31/20182-4N/A0N/A
12/31/20171-5N/A-1N/A
9/30/20171-6N/A-3N/A
6/30/20171-6N/A-3N/A
3/31/20170-4N/A-5N/A
12/31/20160-4N/A-4N/A
9/30/20161-3N/A-4N/A
6/30/20161-2N/A-4N/A
3/31/20161-2N/A-3N/A
12/31/20150-1N/A-2N/A
12/31/201400N/AN/AN/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: ALLR is forecast to remain unprofitable over the next 3 years.

Kazançlar ve Piyasa: ALLR is forecast to remain unprofitable over the next 3 years.

Yüksek Büyüme Kazançları: ALLR is forecast to remain unprofitable over the next 3 years.

Gelir ve Pazar: ALLR is forecast to have no revenue next year.

Yüksek Büyüme Geliri: ALLR is forecast to have no revenue next year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if ALLR's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin